Marijuana Abuse: all 188 studies

Page 1 of 2. Open to participants first (26), then studies with results posted, then the rest; newest registration first within each.

• Delayed-Release, Extended-Release Methylphenidate (Jornay PM) for Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder and Cannabis Use DisorderNot yet recruitingNCT07838311Phase 4
• Lemborexant for Cannabis Use DisorderNot yet recruitingNCT07802990Phase 1/2
• Varenicline as a Treatment for Cannabis Use DisorderNot yet recruitingNCT07783555Phase 2
• Applying Mixed Methods to Identify Links Between PTSD Symptoms, Cannabis Use, and Functional Behaviors With Personalized Feedback Intervention DevelopmentNot yet recruitingNCT07721285Not applicable
• QAIAx - SGI/SI Smart Health Cities: Microcity Enclave Program (Quantum SI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360; USPTO EO 9424 Assignment ID: 2101042 / ARN: REEL/FRAME: 76481/0026 - OUSD-R&E, Department of War)Not yet recruitingNCT07661823Not applicable
• Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use DisorderRecruitingNCT07523633Phase 2
• Trial of Tirzepatide for the Treatment of Cannabis Use DisorderNot yet recruitingNCT07468552Phase 2
• Repeated CBD Administration and Cannabis OutcomesRecruitingNCT07434895Early Phase 1
• Neuroimaging of Adolescent Cannabis Use TreatmentRecruitingNCT07340554Not applicable
• Cohort Study on Medical Students' Mental HealthRecruitingNCT07305701
• Testing the Efficacy of the Cannabis Clinic for Patients With Psychosis (CCP) Intervention for Cannabis Use Reduction/Cessation in Patients With First Episode Psychosis (FEP)Not yet recruitingNCT07245212Not applicable
• RS-tDCS for Cannabis Use Disorder: The C.A.R.E.S. InitiativeRecruitingNCT07184983Not applicable
• Cannabis Abstinence and Neurocognitive Assessment in AdolescenceRecruitingNCT07160153
• Exercise Intervention as Treatment for People Using Cannabis (ExIT-C)RecruitingNCT07091292Not applicable
• Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase PsychosisRecruitingNCT07056894Not applicable
• Cannabis and Processing Emotions StudyRecruitingNCT06907979Not applicable
• A Mobile App to Reduce and/or Quit Cannabis UseRecruitingNCT06733792Not applicable
• Evaluating the Delivery and Effects of THC Vaping Liquids in the BloodstreamNot yet recruitingNCT06334016Early Phase 1
• SCORE Emerging Adult Cannabis Use & StressRecruitingNCT05885542Phase 1/2
• Repetitive Transcranial Magnetic Stimulation for Cannabis Use DisorderRecruitingNCT05859347Not applicable
• Impact of tDCS on Cannabis Craving in SchizophreniaNot yet recruitingNCT05784961Not applicable
• RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic DisordersRecruitingNCT05704582Not applicable
• Characterization of the Pattern of Consumption and Withdrawal Syndrome From Dual Cannabis and Tobacco UseNot yet recruitingNCT05512091
• Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis UseRecruitingNCT05445180Not applicable
• Extended Effects of Cannabis Abstinence on Clinical Symptoms and Cognition in DepressionRecruitingNCT04935619Not applicable
• Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) ScanningRecruitingNCT01730781
• Understanding Effects of Cannabis Use and Abstinence on Neural Glutamate HomeostasisTerminatedNCT05664763Early Phase 1Results posted
• The Effect of Food on the Oral Bioavailability of AEF0117 in Healthy VolunteersTerminatedNCT05451017Phase 1Results posted
• A Trial of Guanfacine-er for Cannabis Use DisorderCompletedNCT05273567Phase 2Results posted
• Varenicline for Co-occurring Cannabis and Tobacco UseCompletedNCT04595318Phase 4Results posted
• UH3 Varenicline for Cannabis Use DisorderCompletedNCT03980561Phase 2Results posted
• Lorcaserin for Cannabis Use DisorderTerminatedNCT03637842Early Phase 1Results posted
• Progesterone for Cannabis WithdrawalCompletedNCT03430050Early Phase 1Results posted
• Brain Imaging of Cannabinoid ReceptorsCompletedNCT03204305Early Phase 1Results posted
• N-Acetylcysteine for Youth Cannabis Use DisorderCompletedNCT03055377Phase 2/3Results posted
• Vaping THC From Electronic CigarettesCompletedNCT02955329Phase 3Results posted
• Facilitating the Behavioral Treatment of Cannabis Use DisorderCompletedNCT02946489Phase 1Results posted
• Effect of Clonazepam on Cannabis Withdrawal and Relapse in Treatment-seeking PatientsCompletedNCT02913924Phase 2Results posted
• Mobile Contingency Management for Marijuana and Tobacco CessationCompletedNCT02869451Not applicableResults posted
• Hormones and Reduction in Co-users of Marijuana and NicotineCompletedNCT02579421Not applicableResults posted
• Pregnenolone and Marijuana DependenceCompletedNCT02439814Phase 2Results posted
• Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and DependenceCompletedNCT02210195Phase 2Results posted
• Buspirone, Stress, and Attentional Bias to Marijuana CuesCompletedNCT02132832Phase 2Results posted
• CBT-I for Cannabis UseTerminatedNCT02102230Not applicableResults posted
• Study of Long-Acting Injectable Naltrexone to Treat Cannabis DependenceCompletedNCT02088177Phase 1/2Results posted
• Baclofen Effects on Marijuana DependenceCompletedNCT02011516Phase 2Results posted
• Effect of Oxytocin on Craving and Therapy ResponseCompletedNCT01827332Not applicableResults posted
• Fixed or Self-Titrated Dosages of Sativex on Cannabis UsersCompletedNCT01748799Not applicableResults posted
• Sativex and Behavioral-relapse Prevention Strategy in Cannabis DependenceCompletedNCT01747850Phase 2Results posted
• Quetiapine Pharmacotherapy for Cannabis DependenceCompletedNCT01697709Phase 2Results posted
• The Role of Sleep in the Treatment of Cannabis Use DisordersCompletedNCT01685073Phase 2/3Results posted
• Achieving Cannabis Cessation-Evaluating N-Acetylcysteine TreatmentCompletedNCT01675661Phase 3Results posted
• Clozapine for Cannabis Use in SchizophreniaCompletedNCT01639872Phase 4Results posted
• Safety and Efficacy of a FAAH-Inhibitor to Treat Cannabis WithdrawalCompletedNCT01618656Phase 2Results posted
• Treatment for Cannabis Withdrawal and DependenceCompletedNCT01611948Phase 2Results posted
• Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With SchizophreniaTerminatedNCT01598896Phase 2/3Results posted
• Vilazodone Treatment for Marijuana DependenceCompletedNCT01574183Phase 2Results posted
• Screening to Augment Referral to Treatment- Project STARTCompletedNCT01539525Not applicableResults posted
• Behavioral Effects of Pregabalin and CannabisCompletedNCT01511640Early Phase 1Results posted
• Open-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis DependenceCompletedNCT01467999Phase 1Results posted
• Nicotine Patch for Marijuana WithdrawalCompletedNCT01400243Phase 4Results posted
• Nabilone for Cannabis Dependence: A Pilot StudyCompletedNCT01347762Phase 2/3Results posted
• Effect of Oxytocin on Stress in Marijuana UsersCompletedNCT01335789Not applicableResults posted
• Cognitive Behavioral Therapy and the Nicotine Transdermal Patch for Cannabis Dependence and Nicotine DependenceCompletedNCT01292642Phase 2Results posted
• Biobehavioral Effects of Topiramate on Cannabis-Related Outcomes in AdolescentsCompletedNCT01110434Phase 2Results posted
• Combined Pharmacotherapy for Cannabis DependencyCompletedNCT01020019Phase 2/3Results posted
• A Trial of N-Acetylcysteine (an Over-the-Counter Medicine) in Adolescents Who Smoke MarijuanaCompletedNCT01005810Phase 2Results posted
• Gabapentin Treatment of Cannabis DependenceCompletedNCT00974376Phase 2Results posted
• Study of Quetiapine Treatment for Cannabis DependenceCompletedNCT00954681Phase 2Results posted
• The Effect of Prescription Medications in Marijuana UsersCompletedNCT00893074Phase 1/2Results posted
• Buspirone Treatment for Marijuana DependenceCompletedNCT00875836Phase 4Results posted
• Dronabinol Interactions With Cognitive Enhancing Drug in HumansCompletedNCT00842985Early Phase 1Results posted
• Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusETerminatedNCT00687609Phase 4Results posted
• Clinical and Neurobiological Effects of Cannabis Dependence in Young AdultsCompletedNCT00656487Phase 2Results posted
• Development and Efficacy Test of Computerized Treatment for Marijuana DependenceCompletedNCT00594659Not applicableResults posted
• Treatment for Adolescent Marijuana AbuseCompletedNCT00580671Not applicableResults posted
• An Open-Label Trial of N-Acetylcysteine in Cannabis Dependent AdolescentsCompletedNCT00542750Phase 1/2Results posted
• Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-UsualCompletedNCT00498550Phase 4Results posted
• Ph1 Marinol Interaction Study - Part 2 - 1CompletedNCT00490269Phase 1Results posted
• Effectiveness Study of Dronabinol and BRENDA for the Treatment of Cannabis WithdrawalCompletedNCT00480441Phase 2Results posted
• Gabapentin Treatment of Cannabis DependenceCompletedNCT00395044Phase 2Results posted
• Comparison Between Marijuana Smoked in Cigarette Paper Versus Cigar PaperCompletedNCT00374127Phase 2Results posted
• Effect of Baclofen on Marijuana Withdrawal and RelapseCompletedNCT00373295Phase 2Results posted
• Atomoxetine Treatment for ADHD and Marijuana DependenceCompletedNCT00360269Phase 2Results posted
• Therapeutic Substance Abuse Treatment in Pregnancy - 1CompletedNCT00227903Phase 2Results posted
• Dronabinol Treatment for Marijuana AddictionCompletedNCT00217971Phase 2Results posted
• Effects of Citicoline on Brain Function and Behavior in Marijuana-Dependent IndividualsCompletedNCT00158249Phase 2Results posted
• Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana DependenceCompletedNCT00149643Phase 2Results posted
• Free Venlafaxine Treatment for Marijuana Addiction and Depression - 1CompletedNCT00131456Phase 2Results posted
• Psilocybin-assisted Treatment for Cannabis Use DisorderActive, not recruitingNCT06660381Phase 1
• Drug-Drug Interaction Between THC and AEF0117WithdrawnNCT06395688Phase 1
• Implementing Screening for Cannabis and Other Drug Use Disorders in Primary Care: Impact on Diagnosis and TreatmentCompletedNCT06249542Not applicable
• Investigating Real-world Stress-related Mechanisms in Heavy Cannabis UsersCompletedNCT05833230Not applicable
• Avatar Intervention for the Treatment of Cannabis Use Disorder in Patients With Severe Mental Health DisordersActive, not recruitingNCT05726617Not applicable
• Validation of the Cannabis Abuse Screening Test in General Practice(GP-CAST)Status unknownNCT05633043
• Joint Effort 2.0: a Mobile Application With University StudentsCompletedNCT05620433Not applicable
• Study of [4-14C] AEF0117 Following a Single Oral Dose in Healthy Male SubjectsCompletedNCT05554926Phase 1
• Mobile Health for Problematic Behaviors and Substance UseStatus unknownNCT05434429Not applicable
• Detecting Drugs of Abuse Via Exhaled Breath Samples Using Differential Mobility SpectrometryCompletedNCT05384470
• Examining Effects of Domain Specific Episodic Future Thinking on Cannabis UseStatus unknownNCT05324813Not applicable

← Marijuana Abuse overview